Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
Bonn et al. urge for a continuation of effective responses implemented during the pandemic, including emergency safe-supply prescribing and housing provision, and further efforts to address the harms of criminalisation and prohibition.
In this webinar, Transform Drug Policy Foundation introduces their proposals for the regulation of stimulants. In doing so, they will lay out a realistic alternative to the prohibition of stimulant drugs.
Correlation-EuroHRN hosts a series of seminars on subjects such as COVID-19's effects on harm reduction efforts for people who use drugs, different approaches to decriminalisation, and more ethical drug policies.